Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results - Butzkueven, H; Kappos, L; Pellegrini, F (J Neurol Neurosurg Psychiatry, 2014)
, et al; TYSABRI Observational Program (TOP) Investigators.